Estrogen Plus Progestin and Lung Cancer in Postmenopausal Women

BACKGROUND: In the post intervention period of the Women’s Health Initiative (WHI) clinical trial, estrogen plus progestin increased total cancer incidence and an adverse influence on lung cancer mortality was suggested. METHODS: We conducted post hoc analyses over the full follow-up period of the W...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chlebowski, Rowan T., Schwartz, Ann G., Wakelee, Heather, Anderson, Garnet L., Stefanick, Marcia L., Manson, JoAnn E., Rodabough, Rebecca J., Chien, Jason W., Wactawski-Wende, Jean, Gass, Margery, Kotchen, Jane Morley, Johnson, Karen C., O’Sullivan, Mary Jo, Ockene, Judith K., Chen, Chu, Hubbell, F. Allan
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2995490/
https://ncbi.nlm.nih.gov/pubmed/19767090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(09)61526-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky